I&E 835 · also PHARM 835
Innovations in Drug Development
Christopher Joseph Chidley, Tso-Pang Yao
Description from DukeHub
Introduction to major issues in developing a drug to treat a disease in an interdisciplinary lecture-based and team-based learning environment. Translation of principles in biomedical sciences, biomedical engineering, and chemistry along with innovative approaches to develop a hypothetical drug for treating a disease of choice. Hypothetical development of model compounds, target analysis, and in vitro and in vivo models to test drug efficacy. Course requires one of the following (or equivalent): Pharmacology and Cancer Biology 533, Chemistry 518, or Biomedical Engineering 577.
Skills
- lab workAI review: "in vitro and in vivo models to test drug efficacy"
AI-resilient: 1 of 5
- No: Physical, lab or field work
- Yes: Live work with people · "team"
- No: Judgment someone is accountable for
- No: A craft you practice with your hands or body
- No: Small, in-person format
The checks lean on Microsoft Research, Working with AI (2025), which found generative AI applies least to physical work and hands-on work with people. A signal, not a promise. How the score works
More in I&E
- Innovation Creativity & Entrepreneurial Mindset I&E 101
- Design Your Duke Journey I&E 110
- Finding Your Voice: Speech, Rhetoric and Story I&E 111S
- Building Global Audiences I&E 250
- Asking Dumb Questions I&E 251
- Social Innovation I&E 261